Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Reversible Fusion Proteins as a Tool to Enhance Uptake of Virus-Functionalized LbL Microcarriers.

Scheffler K, Claus C, Stanifer ML, Boulant S, Reibetanz U.

Biomacromolecules. 2018 Jul 18. doi: 10.1021/acs.biomac.8b00360. [Epub ahead of print]

PMID:
29966082
2.

A PRDX1-p38α heterodimer amplifies MET-driven invasion of IDH-wildtype and IDH-mutant gliomas.

Wirthschaft P, Bode J, Simon AEM, Hoffmann E, van Laack R, Krüwel T, Dietrich F, Bucher D, Hahn A, Sahm F, Breckwoldt MO, Kurz FT, Hielscher T, Fischer B, Dross N, Ruiz de Almodovar C, von Deimling A, Herold-Mende C, Plass C, Boulant S, Wiestler B, Reifenberger G, Lichter P, Wick W, Tews B.

Int J Cancer. 2018 Mar 26. doi: 10.1002/ijc.31404. [Epub ahead of print]

PMID:
29582423
3.

Clathrin-adaptor ratio and membrane tension regulate the flat-to-curved transition of the clathrin coat during endocytosis.

Bucher D, Frey F, Sochacki KA, Kummer S, Bergeest JP, Godinez WJ, Kräusslich HG, Rohr K, Taraska JW, Schwarz US, Boulant S.

Nat Commun. 2018 Mar 16;9(1):1109. doi: 10.1038/s41467-018-03533-0.

4.

Bin1 directly remodels actin dynamics through its BAR domain.

Dräger NM, Nachman E, Winterhoff M, Brühmann S, Shah P, Katsinelos T, Boulant S, Teleman AA, Faix J, Jahn TR.

EMBO Rep. 2017 Nov;18(11):2051-2066. doi: 10.15252/embr.201744137. Epub 2017 Sep 11.

PMID:
28893863
5.

Reovirus inhibits interferon production by sequestering IRF3 into viral factories.

Stanifer ML, Kischnick C, Rippert A, Albrecht D, Boulant S.

Sci Rep. 2017 Sep 7;7(1):10873. doi: 10.1038/s41598-017-11469-6.

6.

Genome packaging of reovirus is mediated by the scaffolding property of the microtubule network.

Shah PNM, Stanifer ML, Höhn K, Engel U, Haselmann U, Bartenschlager R, Kräusslich HG, Krijnse-Locker J, Boulant S.

Cell Microbiol. 2017 Dec;19(12). doi: 10.1111/cmi.12765. Epub 2017 Jul 21.

PMID:
28672089
7.

Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.

Pervolaraki K, Stanifer ML, Münchau S, Renn LA, Albrecht D, Kurzhals S, Senís E, Grimm D, Schröder-Braunstein J, Rabin RL, Boulant S.

Front Immunol. 2017 Apr 21;8:459. doi: 10.3389/fimmu.2017.00459. eCollection 2017.

8.

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.

Martínez C, Rodiño-Janeiro BK, Lobo B, Stanifer ML, Klaus B, Granzow M, González-Castro AM, Salvo-Romero E, Alonso-Cotoner C, Pigrau M, Roeth R, Rappold G, Huber W, González-Silos R, Lorenzo J, de Torres I, Azpiroz F, Boulant S, Vicario M, Niesler B, Santos J.

Gut. 2017 Sep;66(9):1537-1538. doi: 10.1136/gutjnl-2016-311477. Epub 2017 Jan 12.

9.

Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF-β dependent pro-survival signaling.

Stanifer ML, Rippert A, Kazakov A, Willemsen J, Bucher D, Bender S, Bartenschlager R, Binder M, Boulant S.

Cell Microbiol. 2016 Dec;18(12):1831-1845. doi: 10.1111/cmi.12626. Epub 2016 Jul 11.

PMID:
27279006
10.

HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.

Pujol FM, Laketa V, Schmidt F, Mukenhirn M, Müller B, Boulant S, Grimm D, Keppler OT, Fackler OT.

J Virol. 2016 Jul 11;90(15):6709-6723. doi: 10.1128/JVI.00504-16. Print 2016 Aug 1.

11.

Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosis.

Boulant S, Stanifer M, Lozach PY.

Viruses. 2015 Jun 2;7(6):2794-815. doi: 10.3390/v7062747. Review.

12.

Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC.

Nat Immunol. 2014 Aug;15(8):717-26. doi: 10.1038/ni.2915. Epub 2014 Jun 22.

13.

Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking.

Blaising J, Lévy PL, Polyak SJ, Stanifer M, Boulant S, Pécheur EI.

Antiviral Res. 2013 Oct;100(1):215-9. doi: 10.1016/j.antiviral.2013.08.008. Epub 2013 Aug 25.

PMID:
23981392
14.

Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking.

Blaising J, Lévy PL, Gondeau C, Phelip C, Varbanov M, Teissier E, Ruggiero F, Polyak SJ, Oberlies NH, Ivanovic T, Boulant S, Pécheur EI.

Cell Microbiol. 2013 Nov;15(11):1866-82. doi: 10.1111/cmi.12155. Epub 2013 Jun 14.

PMID:
23701235
15.

Similar uptake but different trafficking and escape routes of reovirus virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells.

Boulant S, Stanifer M, Kural C, Cureton DK, Massol R, Nibert ML, Kirchhausen T.

Mol Biol Cell. 2013 Apr;24(8):1196-207. doi: 10.1091/mbc.E12-12-0852. Epub 2013 Feb 20.

16.

Dynamics of intracellular clathrin/AP1- and clathrin/AP3-containing carriers.

Kural C, Tacheva-Grigorova SK, Boulant S, Cocucci E, Baust T, Duarte D, Kirchhausen T.

Cell Rep. 2012 Nov 29;2(5):1111-9. doi: 10.1016/j.celrep.2012.09.025. Epub 2012 Oct 25.

17.

The first five seconds in the life of a clathrin-coated pit.

Cocucci E, Aguet F, Boulant S, Kirchhausen T.

Cell. 2012 Aug 3;150(3):495-507. doi: 10.1016/j.cell.2012.05.047.

18.

Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments.

Strang BL, Boulant S, Kirchhausen T, Coen DM.

MBio. 2012 Feb 7;3(1). pii: e00301-11. doi: 10.1128/mBio.00301-11. Print 2012.

19.

Human cytomegalovirus UL44 concentrates at the periphery of replication compartments, the site of viral DNA synthesis.

Strang BL, Boulant S, Chang L, Knipe DM, Kirchhausen T, Coen DM.

J Virol. 2012 Feb;86(4):2089-95. doi: 10.1128/JVI.06720-11. Epub 2011 Dec 7.

20.

Actin dynamics counteract membrane tension during clathrin-mediated endocytosis.

Boulant S, Kural C, Zeeh JC, Ubelmann F, Kirchhausen T.

Nat Cell Biol. 2011 Aug 14;13(9):1124-31. doi: 10.1038/ncb2307.

21.

Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking.

Ivanovic T, Boulant S, Ehrlich M, Demidenko AA, Arnold MM, Kirchhausen T, Nibert ML.

Traffic. 2011 Sep;12(9):1179-95. doi: 10.1111/j.1600-0854.2011.01233.x. Epub 2011 Jul 7.

22.

Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells.

Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, Bleackley RC, Kirchhausen T, Lieberman J.

Nat Immunol. 2011 Jun 19;12(8):770-7. doi: 10.1038/ni.2050.

23.

Peroxisomes are signaling platforms for antiviral innate immunity.

Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC.

Cell. 2010 May 14;141(4):668-81. doi: 10.1016/j.cell.2010.04.018. Epub 2010 May 6.

24.

Lipid metabolism and HCV infection.

Targett-Adams P, Boulant S, Douglas MW, McLauchlan J.

Viruses. 2010 May;2(5):1195-217. doi: 10.3390/v2051195. Epub 2010 May 11.

25.

Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication.

Strang BL, Boulant S, Coen DM.

J Virol. 2010 Feb;84(4):1771-84. doi: 10.1128/JVI.01510-09. Epub 2009 Dec 9.

26.

Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.

Angus AG, Dalrymple D, Boulant S, McGivern DR, Clayton RF, Scott MJ, Adair R, Graham S, Owsianka AM, Targett-Adams P, Li K, Wakita T, McLauchlan J, Lemon SM, Patel AH.

J Gen Virol. 2010 Jan;91(Pt 1):122-32. doi: 10.1099/vir.0.015909-0. Epub 2009 Sep 30.

27.

Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein.

Roohvand F, Maillard P, Lavergne JP, Boulant S, Walic M, Andréo U, Goueslain L, Helle F, Mallet A, McLauchlan J, Budkowska A.

J Biol Chem. 2009 May 15;284(20):13778-91. doi: 10.1074/jbc.M807873200. Epub 2009 Mar 6.

28.

Subcellular localizations of the hepatitis C virus alternate reading frame proteins.

Ratinier M, Boulant S, Crussard S, McLauchlan J, Lavergne JP.

Virus Res. 2009 Jan;139(1):106-10. doi: 10.1016/j.virusres.2008.09.011. Epub 2008 Nov 28.

PMID:
18996421
29.

Transcriptional slippage prompts recoding in alternate reading frames in the hepatitis C virus (HCV) core sequence from strain HCV-1.

Ratinier M, Boulant S, Combet C, Targett-Adams P, McLauchlan J, Lavergne JP.

J Gen Virol. 2008 Jul;89(Pt 7):1569-78. doi: 10.1099/vir.0.83614-0.

PMID:
18559926
30.

Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner.

Boulant S, Douglas MW, Moody L, Budkowska A, Targett-Adams P, McLauchlan J.

Traffic. 2008 Aug;9(8):1268-82. doi: 10.1111/j.1600-0854.2008.00767.x. Epub 2008 May 17.

31.

Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production.

Targett-Adams P, Hope G, Boulant S, McLauchlan J.

J Biol Chem. 2008 Jun 13;283(24):16850-9. doi: 10.1074/jbc.M802273200. Epub 2008 Apr 18.

32.

Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication.

Targett-Adams P, Boulant S, McLauchlan J.

J Virol. 2008 Mar;82(5):2182-95. Epub 2007 Dec 19.

33.

The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly.

Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R.

J Biol Chem. 2007 Dec 21;282(51):37158-69. Epub 2007 Oct 17.

34.
35.

Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries.

Fiorucci M, Boulant S, Fournillier A, Abraham JD, Lavergne JP, Paranhos-Baccala G, Inchauspé G, Bain C.

J Gen Virol. 2007 Apr;88(Pt 4):1149-62.

PMID:
17374758
36.

Structural determinants that target the hepatitis C virus core protein to lipid droplets.

Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, Lavergne JP, Penin F, McLauchlan J.

J Biol Chem. 2006 Aug 4;281(31):22236-47. Epub 2006 May 16.

37.

Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne JP.

J Virol. 2005 Sep;79(17):11353-65.

38.

Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA.

Boni S, Lavergne JP, Boulant S, Cahour A.

J Biol Chem. 2005 May 6;280(18):17737-48. Epub 2005 Mar 9.

39.

The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro.

Cristofari G, Ivanyi-Nagy R, Gabus C, Boulant S, Lavergne JP, Penin F, Darlix JL.

Nucleic Acids Res. 2004 May 11;32(8):2623-31. Print 2004.

40.

Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b.

Boulant S, Becchi M, Penin F, Lavergne JP.

J Biol Chem. 2003 Nov 14;278(46):45785-92. Epub 2003 Sep 2.

Supplemental Content

Loading ...
Support Center